NEW YORK (GenomeWeb News) – Galapagos said today that it has acquired the drug discovery services assets of Cambridge, UK-based Sareum Holdings for €695,000 ($1 million).
Sareum’s drug discovery services business uses x-ray crystallography to identify chemical fragments for recombination into lead compounds. The services and technology assets will be integrated into Galapagos’ BioFocus DPI unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.